Apella Capital LLC Raises Holdings in Doximity, Inc. (NASDAQ:DOCS)

Apella Capital LLC grew its stake in Doximity, Inc. (NASDAQ:DOCS) by 10.4% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 69,320 shares of the company’s stock after buying an additional 6,553 shares during the quarter. Apella Capital LLC’s holdings in Doximity were worth $3,701,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Farther Finance Advisors LLC grew its holdings in Doximity by 324.2% during the 3rd quarter. Farther Finance Advisors LLC now owns 789 shares of the company’s stock worth $34,000 after acquiring an additional 603 shares in the last quarter. Morse Asset Management Inc purchased a new position in Doximity in the third quarter valued at $46,000. GAMMA Investing LLC raised its stake in Doximity by 40.1% in the third quarter. GAMMA Investing LLC now owns 1,439 shares of the company’s stock valued at $63,000 after buying an additional 412 shares in the last quarter. Quarry LP raised its stake in Doximity by 101.2% in the second quarter. Quarry LP now owns 1,616 shares of the company’s stock valued at $45,000 after buying an additional 131,253 shares in the last quarter. Finally, Covestor Ltd lifted its holdings in Doximity by 441.9% during the 3rd quarter. Covestor Ltd now owns 1,680 shares of the company’s stock worth $73,000 after buying an additional 1,370 shares during the last quarter. 87.19% of the stock is owned by institutional investors and hedge funds.

Doximity Price Performance

Shares of DOCS opened at $50.68 on Wednesday. Doximity, Inc. has a 1-year low of $22.96 and a 1-year high of $61.75. The firm has a 50 day simple moving average of $53.40 and a 200-day simple moving average of $42.09. The stock has a market cap of $9.46 billion, a price-to-earnings ratio of 58.25, a price-to-earnings-growth ratio of 4.13 and a beta of 1.38.

Analysts Set New Price Targets

DOCS has been the topic of several research analyst reports. Raymond James reissued an “outperform” rating and set a $65.00 target price (up previously from $37.00) on shares of Doximity in a research report on Friday, November 8th. Evercore ISI boosted their price objective on shares of Doximity from $34.00 to $45.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 8th. Canaccord Genuity Group reaffirmed a “hold” rating and issued a $60.00 target price (up from $40.00) on shares of Doximity in a research report on Wednesday, November 13th. Canaccord Genuity Group cut shares of Doximity from a “buy” rating to a “hold” rating and boosted their price target for the company from $40.00 to $60.00 in a research report on Wednesday, November 13th. Finally, The Goldman Sachs Group assumed coverage on Doximity in a report on Friday, November 15th. They set a “neutral” rating and a $58.00 price objective on the stock. Thirteen analysts have rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $53.12.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.